GeneDx Holdings (WGS) Non-Current Assets (2020 - 2026)
GeneDx Holdings (WGS) reported Non-Current Assets of $235.7 million for Q1 2026, up 6.83% year-over-year from $220.6 million in Q1 2025, and down 7.73% quarter-over-quarter from $255.4 million in Q4 2025.
GeneDx Holdings (WGS) Non-Current Assets (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 7 years of Non-Current Assets data on file, last reported at $235.7 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $235.7 million, up 6.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 12.86% YoY), and the FY2025 annual result was $255.4 million, up 15.36% from the prior year.
- Non-Current Assets declined to $235.7 million in Q1 2026 per WGS's latest filing, from $255.4 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $530.6 million in Q2 2022 and troughed at $107.2 million in Q1 2022.
- A 5-year average of $269.8 million and a median of $245.5 million in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets soared 705.55% in 2022, then slumped 53.01% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $278.3 million in 2022, then decreased by 15.06% to $236.4 million in 2023, then retreated by 6.35% to $221.4 million in 2024, then rose by 15.36% to $255.4 million in 2025, then dropped by 7.73% to $235.7 million in 2026.
- Business Quant data shows WGS's Non-Current Assets at $235.7 million in Q1 2026, $255.4 million in Q4 2025, and $256.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 20.47 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 90.97 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 69.61 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 1.93 Bn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 8.30 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 23.46 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 962.59 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 3.82 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 2.34 Bn |
| 10 | GeneDx Holdings | 1.52 Bn | 1.35 Bn | 68.21 Mn | 235.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235.67 Mn |
| Dec 31, 2025 | 255.42 Mn |
| Sep 30, 2025 | 256.32 Mn |
| Jun 30, 2025 | 259.03 Mn |
| Mar 31, 2025 | 220.61 Mn |
| Dec 31, 2024 | 221.41 Mn |
| Sep 30, 2024 | 222.83 Mn |
| Jun 30, 2024 | 226.93 Mn |
| Mar 31, 2024 | 231.10 Mn |
| Dec 31, 2023 | 236.42 Mn |
| Sep 30, 2023 | 245.47 Mn |
| Jun 30, 2023 | 263.11 Mn |
| Mar 31, 2023 | 272.95 Mn |
| Dec 31, 2022 | 278.32 Mn |
| Sep 30, 2022 | 522.36 Mn |
| Jun 30, 2022 | 530.58 Mn |
| Mar 31, 2022 | 107.25 Mn |
| Dec 31, 2021 | 70.55 Mn |
| Sep 30, 2021 | 64.85 Mn |
| Jun 30, 2021 | 76.52 Mn |